Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021
Jennifer Griffin, Meredith Haddix, Phoebe Danza, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 34, pp. 1170-1176
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
Science (2021) Vol. 374, Iss. 6572
Open Access | Times Cited: 782
Considerations in boosting COVID-19 vaccine immune responses
Philip R. Krause, Thomas R. Fleming, Richard Peto, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1377-1380
Open Access | Times Cited: 352
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
Heather M. Scobie, Amelia G. Johnson, Amitabh B. Suthar, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 37, pp. 1284-1290
Open Access | Times Cited: 289
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Lindsey Wang, QuanQiu Wang, Pamela B. Davis, et al.
World Psychiatry (2021) Vol. 21, Iss. 1, pp. 124-132
Open Access | Times Cited: 124
Strategies That Promote Equity in COVID-19 Vaccine Uptake for Black Communities: a Review
Debbie Dada, Joseph Nguemo Djiometio, SarahAnn M. McFadden, et al.
Journal of Urban Health (2022) Vol. 99, Iss. 1, pp. 15-27
Open Access | Times Cited: 120
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar
Adeel A. Butt, Soha R. Dargham, Hiam Chemaitelly, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 197-197
Open Access | Times Cited: 101
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2773-2787
Open Access | Times Cited: 69
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2021) Vol. 139, Iss. 10, pp. 1588-1592
Open Access | Times Cited: 82
Making waves: Wastewater surveillance of SARS-CoV-2 in an endemic future
Fuqing Wu, Wei Lin Lee, Hongjie Chen, et al.
Water Research (2022) Vol. 219, pp. 118535-118535
Open Access | Times Cited: 62
Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Ramy Mohamed Ghazy, Rasha Ashmawy, Noha Alaa Hamdy, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 350-350
Open Access | Times Cited: 58
COVID-19 Pandemic and Im/migrants’ Elevated Health Concerns in Canada: Vaccine Hesitancy, Anticipated Stigma, and Risk Perception of Accessing Care
Shen Lin
Journal of Immigrant and Minority Health (2022) Vol. 24, Iss. 4, pp. 896-908
Open Access | Times Cited: 49
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
Patricia Almendro-Vázquez, Marta Chivite‐Lacaba, Alberto Utrero‐Rico, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Direct health care costs associated with COVID-19 in the United States
Jessica K. DeMartino, Elyse Swallow, Debbie Goldschmidt, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 9, pp. 936-947
Closed Access | Times Cited: 26
Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021
Alexandre R. Marra, João Luiz Miraglia, Daniel Tavares Malheiros, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e360-e366
Open Access | Times Cited: 24
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains
Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Gabriela D. A. Guardia, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 827-827
Open Access | Times Cited: 23
COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA
Thomas N. Vilches, Pratha Sah, Seyed M. Moghadas, et al.
The Lancet Regional Health - Americas (2021) Vol. 6, pp. 100147-100147
Open Access | Times Cited: 28
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
Kim Bouillon, Bérangère Baricault, Jérémie Botton, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000104-e000104
Open Access | Times Cited: 18
Understanding COVID-19 Vaccine Effectiveness against Death Using a Novel Measure: COVID Excess Mortality Percentage
Vladimir A. Atanasov, Natalia Barreto, Jeff Whittle, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 379-379
Open Access | Times Cited: 10
Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States
Radhika Gharpure, Samira Sami, Johanna Vostok, et al.
Emerging infectious diseases (2021) Vol. 28, Iss. 1, pp. 36-44
Open Access | Times Cited: 26
The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study
Finlay A. McAlister, Majid Nabipoor, Anna Chu, et al.
CMAJ Open (2022) Vol. 10, Iss. 2, pp. E400-E408
Open Access | Times Cited: 17
Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
Vasiliki Georgakopoulou, Aikaterini Gkoufa, Aristeidis Tsakanikas, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 9
Unveiling the Impact of COVID-19 Vaccines: A Meta-Analysis of Survival Rates Among Patients in the United States Based on Vaccination Status
Anderson E Ikeokwu, Rebecca Lawrence, Egbaoghene D Osieme, et al.
Cureus (2023)
Open Access | Times Cited: 9
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top